Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity
Part of paid clinical trials in New York, New York.
- Sponsor
- Hospital for Special Surgery, New York
- Study ID
- NCT02255331
- Status
- Recruiting
Conditions
- Complications; Arthroplasty
- Complications; Arthroplasty, Mechanical
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 95 Years
- Healthy Volunteers
- Not accepted
Study Details
Patients with a total hip replacement may require early revision surgery due to an adverse local tissue reaction or bone resorption that occurs due to wear debris released from the implant. MRI provides a non-invasive biomarker for clinicians and surgeons to detect early adverse synovial reactions which may exist in the absence of clinical symptoms, thus imparting essential information for clinical management. This study will address two of the most commons causes of hip implant failure, including adverse local tissue reaction in implants not traditionally associated with adverse tissue reactions, as well as the presence of aseptic loosening and loss of implant-bone integration.
Key Dates
- Start date
- Sep 15, 2017
- Status verified
- Jun 2024
- Primary completion
- May 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 240 participants (estimated)
Arms
- Arm: Retrieval AnalysisYou qualify for this Retrieval Analysis study if you: 1. Have a total hip replacement with a ceramic component undergoing revision for any reason, including recurrent dislocation. 2. Have a metal-on-polyethylene total hip replacement and have repeated dislocation, or 3. Have a metal-on-polyethylene total hip replacement greater than 1 year old, or 4. Have an infected total hip replacement (any surface bearing) You do not qualify for this arm of the study if you: 1. Have occupational exposure to cobalt or chromium 2. Presence of a metal-on-metal (MOM) implant, or a recalled implant 3. Have had a prior revision of your total hip 4. Standard contra-indications to MRI (e.g. cardiac pacemaker, etc.)
- Arm: Longitudinal EvaluationYou qualify for this arm of the study if you: 1. Have a total hip replacement with a ceramic component 2. Have a metal-on-polyethylene total hip replacement. 3. Have your original or revised total hip replacement. You do not qualify for this arm of the study if you: 1. Have occupational exposure to cobalt or chromium 2. Have cemented components. 3. Presence of a metal-on-metal (MOM) implant, or a recalled implant 4. Standard contra-indications to MRI (e.g. cardiac pacemaker, etc.)
Primary Outcome Measure
Utilize MRI to evaluate total hip arthroplasty designs traditionally not implicated with the presence of adverse local tissue reactions. [ Time Frame: An expected average of 1 year post-operatively ]
Central Contacts
- Matthew F Koff, PhD212-774-2103
- Mauro Miranda, MFA212-774-1979
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital for Special Surgery | New York | New York | 10021 | Matthew F Koff, PhD (PRINCIPAL_INVESTIGATOR) Hollis G Potter, MD (PRINCIPAL_INVESTIGATOR) |